Transcranial Magnetic Stimulation in the Treatment Of Anxiety Disorders

Abstract

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article(s) and complete the quiz and evaluation assessment survey on the enclosed form, answering at least 80% of the quiz questions correctly. This activity expires on January 31, 2014. Anxiety disorders are more common than depression in the United States, with an overall lifetime prevalence of 29%, and a 12-month prevalence of 18%. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR), lists (from most to least prevalent): specific phobia (lifetime 12.5%, 12-month 8.7%); social anxiety disorder (SAD) (12.1%, 6.8%); posttraumatic stress disorder (PTSD) (6.8%, 3.5%); generalized anxiety disorder (GAD) (5.7%, 3.1%); panic disorder (PD) (4.7%, 2.7%); and obsessive-compulsive disorder (OCD) (1.6%, 1.0%). The DSM-V revisions proposed for these disorders involve minor changes in criteria while maintaining the current subclassification. The level of functional impairment for most people with anxiety disorders is significant, and related estiAfter participating in this CME activity, the psychiatrist should be better able to: